세계의 실시간 PCR 키트 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)
Real Time PCR Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1873367
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 실시간 PCR 키트 시장 규모는 2024년에 29억 2,500만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 7.3%로 성장하여 2031년까지 47억 5,700만 달러로 확대될 것으로 예측됩니다.
본 보고서는 실시간 PCR 키트의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축, 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.
실시간 PCR(중합효소 연쇄 반응) 키트는 핵산(DNA 또는 RNA)의 증폭과 동시 정량을 실시간으로 수행하는 진단 및 조사 도구입니다. 이러한 키트에는 일반적으로 형광 기반 검출에 최적화된 효소, 프라이머, 프로브 및 완충 시스템이 포함되어 있습니다. 분자진단 분야에서 널리 활용되고 있으며, 감염병 검출(예 : COVID-19, HIV), 암 유전자 발현 분석, 유전자 돌연변이 스크리닝, 식품 안전 검사 등에 활용되고 있습니다.
실시간 PCR 키트 시장은 임상, 연구 및 산업 분야에서 신속하고 정확하며 처리량이 높은 진단 도구에 대한 수요가 증가하면서 시장을 주도하고 있습니다. COVID-19 팬데믹 상황에서 실시간 PCR이 광범위하게 사용되면서 전 세계적으로 보급과 인프라가 크게 확대되었습니다. 또한, 분자진단에 대한 투자 증가, 감염성 질환, 유전성 질환 및 암 발생률 증가, 다중화 및 휴대용 PCR 기술의 발전으로 인해 시장은 지속적으로 성장하고 있습니다. 맞춤형 의료와 질병 조기 발견에 대한 중요성이 높아지는 것도 장기적인 수요를 뒷받침하고 있습니다.
그러나 광범위한 사용에도 불구하고 실시간 PCR 키트 시장은 몇 가지 도전에 직면해 있습니다. 특히 자원이 한정된 환경에서는 시약과 장비의 높은 비용을 들 수 있습니다. 또한, 기술적 복잡성, 숙련된 인력의 필요성, 오염 위험이 검사의 신뢰성에 영향을 미칠 수 있습니다. 또한, 민감도 향상과 간소화된 워크플로우를 제공하는 디지털 PCR, 등온증폭법 등 새로운 기술의 등장으로 시장 경쟁은 점점 더 치열해지고 있습니다. 규제 장벽과 분석 설계의 지속적인 혁신의 필요성도 신규 진입 장벽을 더욱 높이고 있습니다.
실시간 PCR 키트의 분류에는 2단계 실시간 PCR과 원스텝 실시간 PCR이 포함됩니다. 대부분의 실시간 PCR 키트는 원스텝 실시간 PCR이며, 2024년 이미징 비율은 약 63.88%를 기록할 것으로 예상됩니다. 실시간 PCR 키트는 감염, 암 등의 분야에서 널리 활용되고 있습니다. 2024년 기준 감염병 분야 사용 비중이 가장 높아 약 68.27%를 차지하고 있습니다. 북미는 가장 큰 판매 지역으로 2024년 소비액 시장 점유율은 약 41.14%에 달합니다. 북미에 이어 유럽은 26.66%의 소비 시장 점유율로 두 번째로 큰 판매 지역입니다. 시장 경쟁이 치열합니다. Roche, Abbott, Agilent Technologies, Qiagen, Thermo Fisher Scientific 등이 업계 선두주자이며, 주요 기술과 특허를 보유하고 있으며, 하이엔드 고객을 보유하고 있습니다.
이 보고서는 지역별, 국가별, 유형별, 용도별 실시간 PCR 키트 분석과 함께 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞춘 세계 실시간 PCR 키트 시장에 대한 종합적인 정보를 제공하는 것을 목표로 합니다.
2024년을 기준 연도, 2020년에서 2031년까지의 과거 및 예측 데이터와 함께 판매량(백만 단위) 및 매출액(백만 달러)으로 실시간 PCR 키트의 시장 규모 추정 및 예측을 제시합니다. 정량적, 정성적 분석을 통해 독자들이 실시간 PCR 키트 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 돕습니다.
시장 세분화
기업별
Roche
Abbott
Agilent Technologies
Qiagen
Thermo Fisher Scientific
DAAN Gene
Hologic
Diagenode
Bio-Rad
Takara Bio
Meridian Bioscience
Toyobo
SSI Diagnostica
Genekam
BGI
Sansure Biotech
YHLO
ACON
유형별 부문
원스텝 실시간 PCR
투스텝 실시간 PCR
용도별 부문
감염증
암
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSM
영문 목차
영문목차
The global market for Real Time PCR Kits was estimated to be worth US$ 2925 million in 2024 and is forecast to a readjusted size of US$ 4757 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Real Time PCR Kits cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Real-Time PCR (Polymerase Chain Reaction) kits are diagnostic or research tools that enable the amplification and simultaneous quantification of nucleic acids (DNA or RNA) in real time. These kits typically include enzymes, primers, probes, and buffer systems optimized for fluorescence-based detection. They are widely used in molecular diagnostics, including infectious disease detection (e.g., COVID-19, HIV), cancer gene expression analysis, genetic mutation screening, and food safety testing.
The Real-Time PCR kits market is driven by the growing demand for rapid, accurate, and high-throughput diagnostic tools in clinical, research, and industrial applications. The widespread use of real-time PCR during the COVID-19 pandemic significantly expanded its global adoption and infrastructure. Additionally, increasing investments in molecular diagnostics, rising incidences of infectious diseases, genetic disorders, and cancer, as well as advancements in multiplexing and portable PCR technologies, continue to boost the market. The growing emphasis on personalized medicine and early disease detection also supports long-term demand.
Despite its widespread use, the real-time PCR kits market faces several challenges, including high cost of reagents and instruments, especially in resource-limited settings. Moreover, technical complexity, need for skilled personnel, and the risk of contamination can affect test reliability. The market is also becoming increasingly competitive, with pressure from emerging technologies such as digital PCR and isothermal amplification methods, which offer enhanced sensitivity and simpler workflows. Regulatory hurdles and the need for continuous innovation in assay design further add to the barriers for new entrants.
The classification of Real Time PCR Kits includes Two-step Real Time PCR and One-step Real Time PCR, and most of Real Time PCR Kits is One-step Real Time PCR, the proportion of imaging in 2024 is about 63.88%. Real Time PCR Kits is widely used for the Infectious Disease, Cancer and others. The most proportion of Real Time PCR Kits is used in the Infectious Disease with the proportion is about 68.27% in 2024. North America is the largest sales place, with a consumption value market share nearly 41.14% in 2024. Following North America, Europe is the second largest sales place with the consumption market share of 26.66%. Market competition is intense. Roche, Abbott, Agilent Technologies, Qiagen, Thermo Fisher Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Real Time PCR Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Real Time PCR Kits by region & country, by Type, and by Application.
The Real Time PCR Kits market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real Time PCR Kits.
Market Segmentation
By Company
Roche
Abbott
Agilent Technologies
Qiagen
Thermo Fisher Scientific
DAAN Gene
Hologic
Diagenode
Bio-Rad
Takara Bio
Meridian Bioscience
Toyobo
SSI Diagnostica
Genekam
BGI
Sansure Biotech
YHLO
ACON
Segment by Type
One-step Real Time PCR
Two-step Real Time PCR
Segment by Application
Infectious Disease
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Real Time PCR Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Real Time PCR Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Real Time PCR Kits in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Real Time PCR Kits Product Introduction
1.2 Global Real Time PCR Kits Market Size Forecast
1.2.1 Global Real Time PCR Kits Sales Value (2020-2031)
1.2.2 Global Real Time PCR Kits Sales Volume (2020-2031)
1.2.3 Global Real Time PCR Kits Sales Price (2020-2031)
1.3 Real Time PCR Kits Market Trends & Drivers
1.3.1 Real Time PCR Kits Industry Trends
1.3.2 Real Time PCR Kits Market Drivers & Opportunity
1.3.3 Real Time PCR Kits Market Challenges
1.3.4 Real Time PCR Kits Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Real Time PCR Kits Players Revenue Ranking (2024)
2.2 Global Real Time PCR Kits Revenue by Company (2020-2025)
2.3 Global Real Time PCR Kits Players Sales Volume Ranking (2024)
2.4 Global Real Time PCR Kits Sales Volume by Company Players (2020-2025)
2.5 Global Real Time PCR Kits Average Price by Company (2020-2025)
2.6 Key Manufacturers Real Time PCR Kits Manufacturing Base and Headquarters
2.7 Key Manufacturers Real Time PCR Kits Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Real Time PCR Kits
2.9 Real Time PCR Kits Market Competitive Analysis
2.9.1 Real Time PCR Kits Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Real Time PCR Kits Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real Time PCR Kits as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 One-step Real Time PCR
3.1.2 Two-step Real Time PCR
3.2 Global Real Time PCR Kits Sales Value by Type
3.2.1 Global Real Time PCR Kits Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Real Time PCR Kits Sales Value, by Type (2020-2031)
3.2.3 Global Real Time PCR Kits Sales Value, by Type (%) (2020-2031)
3.3 Global Real Time PCR Kits Sales Volume by Type
3.3.1 Global Real Time PCR Kits Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Real Time PCR Kits Sales Volume, by Type (2020-2031)
3.3.3 Global Real Time PCR Kits Sales Volume, by Type (%) (2020-2031)
3.4 Global Real Time PCR Kits Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infectious Disease
4.1.2 Cancer
4.1.3 Other
4.2 Global Real Time PCR Kits Sales Value by Application
4.2.1 Global Real Time PCR Kits Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Real Time PCR Kits Sales Value, by Application (2020-2031)
4.2.3 Global Real Time PCR Kits Sales Value, by Application (%) (2020-2031)
4.3 Global Real Time PCR Kits Sales Volume by Application
4.3.1 Global Real Time PCR Kits Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Real Time PCR Kits Sales Volume, by Application (2020-2031)
4.3.3 Global Real Time PCR Kits Sales Volume, by Application (%) (2020-2031)
4.4 Global Real Time PCR Kits Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Real Time PCR Kits Sales Value by Region
5.1.1 Global Real Time PCR Kits Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Real Time PCR Kits Sales Value by Region (2020-2025)
5.1.3 Global Real Time PCR Kits Sales Value by Region (2026-2031)
5.1.4 Global Real Time PCR Kits Sales Value by Region (%), (2020-2031)
5.2 Global Real Time PCR Kits Sales Volume by Region
5.2.1 Global Real Time PCR Kits Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Real Time PCR Kits Sales Volume by Region (2020-2025)
5.2.3 Global Real Time PCR Kits Sales Volume by Region (2026-2031)
5.2.4 Global Real Time PCR Kits Sales Volume by Region (%), (2020-2031)
5.3 Global Real Time PCR Kits Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Real Time PCR Kits Sales Value, 2020-2031
5.4.2 North America Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Real Time PCR Kits Sales Value, 2020-2031
5.5.2 Europe Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Real Time PCR Kits Sales Value, 2020-2031
5.6.2 Asia Pacific Real Time PCR Kits Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Real Time PCR Kits Sales Value, 2020-2031
5.7.2 South America Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Real Time PCR Kits Sales Value, 2020-2031
5.8.2 Middle East & Africa Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Real Time PCR Kits Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Real Time PCR Kits Sales Value and Sales Volume
6.2.1 Key Countries/Regions Real Time PCR Kits Sales Value, 2020-2031
6.2.2 Key Countries/Regions Real Time PCR Kits Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Real Time PCR Kits Sales Value, 2020-2031
6.3.2 United States Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Real Time PCR Kits Sales Value, 2020-2031
6.4.2 Europe Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Real Time PCR Kits Sales Value, 2020-2031
6.5.2 China Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.5.3 China Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Real Time PCR Kits Sales Value, 2020-2031
6.6.2 Japan Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Real Time PCR Kits Sales Value, 2020-2031
6.7.2 South Korea Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Real Time PCR Kits Sales Value, 2020-2031
6.8.2 Southeast Asia Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Real Time PCR Kits Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Real Time PCR Kits Sales Value, 2020-2031
6.9.2 India Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
6.9.3 India Real Time PCR Kits Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Roche Real Time PCR Kits Product Offerings
7.1.5 Roche Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Abbott Real Time PCR Kits Product Offerings
7.2.5 Abbott Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Information
7.3.2 Agilent Technologies Introduction and Business Overview
7.3.3 Agilent Technologies Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Agilent Technologies Real Time PCR Kits Product Offerings
7.3.5 Agilent Technologies Recent Development
7.4 Qiagen
7.4.1 Qiagen Company Information
7.4.2 Qiagen Introduction and Business Overview
7.4.3 Qiagen Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Qiagen Real Time PCR Kits Product Offerings
7.4.5 Qiagen Recent Development
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Information
7.5.2 Thermo Fisher Scientific Introduction and Business Overview
7.5.3 Thermo Fisher Scientific Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Thermo Fisher Scientific Real Time PCR Kits Product Offerings
7.5.5 Thermo Fisher Scientific Recent Development
7.6 DAAN Gene
7.6.1 DAAN Gene Company Information
7.6.2 DAAN Gene Introduction and Business Overview
7.6.3 DAAN Gene Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 DAAN Gene Real Time PCR Kits Product Offerings
7.6.5 DAAN Gene Recent Development
7.7 Hologic
7.7.1 Hologic Company Information
7.7.2 Hologic Introduction and Business Overview
7.7.3 Hologic Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hologic Real Time PCR Kits Product Offerings
7.7.5 Hologic Recent Development
7.8 Diagenode
7.8.1 Diagenode Company Information
7.8.2 Diagenode Introduction and Business Overview
7.8.3 Diagenode Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Diagenode Real Time PCR Kits Product Offerings
7.8.5 Diagenode Recent Development
7.9 Bio-Rad
7.9.1 Bio-Rad Company Information
7.9.2 Bio-Rad Introduction and Business Overview
7.9.3 Bio-Rad Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Bio-Rad Real Time PCR Kits Product Offerings
7.9.5 Bio-Rad Recent Development
7.10 Takara Bio
7.10.1 Takara Bio Company Information
7.10.2 Takara Bio Introduction and Business Overview
7.10.3 Takara Bio Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Takara Bio Real Time PCR Kits Product Offerings
7.10.5 Takara Bio Recent Development
7.11 Meridian Bioscience
7.11.1 Meridian Bioscience Company Information
7.11.2 Meridian Bioscience Introduction and Business Overview
7.11.3 Meridian Bioscience Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Meridian Bioscience Real Time PCR Kits Product Offerings
7.11.5 Meridian Bioscience Recent Development
7.12 Toyobo
7.12.1 Toyobo Company Information
7.12.2 Toyobo Introduction and Business Overview
7.12.3 Toyobo Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Toyobo Real Time PCR Kits Product Offerings
7.12.5 Toyobo Recent Development
7.13 SSI Diagnostica
7.13.1 SSI Diagnostica Company Information
7.13.2 SSI Diagnostica Introduction and Business Overview
7.13.3 SSI Diagnostica Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 SSI Diagnostica Real Time PCR Kits Product Offerings
7.13.5 SSI Diagnostica Recent Development
7.14 Genekam
7.14.1 Genekam Company Information
7.14.2 Genekam Introduction and Business Overview
7.14.3 Genekam Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Genekam Real Time PCR Kits Product Offerings
7.14.5 Genekam Recent Development
7.15 BGI
7.15.1 BGI Company Information
7.15.2 BGI Introduction and Business Overview
7.15.3 BGI Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 BGI Real Time PCR Kits Product Offerings
7.15.5 BGI Recent Development
7.16 Sansure Biotech
7.16.1 Sansure Biotech Company Information
7.16.2 Sansure Biotech Introduction and Business Overview
7.16.3 Sansure Biotech Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Sansure Biotech Real Time PCR Kits Product Offerings
7.16.5 Sansure Biotech Recent Development
7.17 YHLO
7.17.1 YHLO Company Information
7.17.2 YHLO Introduction and Business Overview
7.17.3 YHLO Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 YHLO Real Time PCR Kits Product Offerings
7.17.5 YHLO Recent Development
7.18 ACON
7.18.1 ACON Company Information
7.18.2 ACON Introduction and Business Overview
7.18.3 ACON Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)